Gross Profit Trends Compared: Amgen Inc. vs Walgreens Boots Alliance, Inc.

Amgen vs Walgreens: A Decade of Gross Profit Trends

__timestampAmgen Inc.Walgreens Boots Alliance, Inc.
Wednesday, January 1, 20141564100000021569000000
Thursday, January 1, 20151743500000026753000000
Friday, January 1, 20161882900000029874000000
Sunday, January 1, 20171878000000029162000000
Monday, January 1, 20181964600000030792000000
Tuesday, January 1, 20191900600000028159000000
Wednesday, January 1, 20201926500000026077000000
Friday, January 1, 20211952500000028067000000
Saturday, January 1, 20221991700000028266000000
Sunday, January 1, 20231977500000027072000000
Monday, January 1, 20242056600000026524000000
Loading chart...

Unleashing the power of data

Gross Profit Trends: Amgen Inc. vs Walgreens Boots Alliance, Inc.

In the ever-evolving landscape of the pharmaceutical and retail sectors, understanding financial trends is crucial. From 2014 to 2023, Amgen Inc. and Walgreens Boots Alliance, Inc. have showcased distinct trajectories in their gross profit margins. Amgen Inc., a leader in biotechnology, has seen a steady increase in gross profit, peaking in 2022 with a 27% rise from 2014. Meanwhile, Walgreens Boots Alliance, a retail pharmacy giant, experienced a 43% increase in gross profit by 2018, before a slight decline in recent years. Notably, 2023 data reveals a 12% drop from its 2018 peak. This divergence highlights the resilience of biotech amidst market fluctuations and the challenges faced by retail pharmacies. Missing data for Amgen in 2024 suggests a need for cautious optimism. These insights offer a window into the strategic maneuvers of these industry titans.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025